Asklepios Bio Pharmaceutical, Inc. announced it raised $200 Million in an initial filing from an offering of $200 Million

May 29, 2019•over 6 years ago

Amount Raised

$200 Million

DurhamBiotechnology

Company Information

Company

Asklepios BioPharmaceutical, Inc.

Location

20 TW ALEXANDER DRIVE

Durham, North Carolina, United States

About

AskBio is a leading, clinical-stage gene therapy company dedicated to developing AAV gene therapies for genetic disorders. Learn more about our gene therapy technology and current clinical trials.

Related People

9 contacts

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Asklepios Bio Pharmaceutical, Inc. announced it raised $200 Million in an initial filing from an offering of $200 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information